Cellectar Biosciences Inc.

(CLRB) Trade

By |

Profile

Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.

Contact Information

Website: www.cellectar.com
Email: epiros@rodmanandrenshaw.com
Main Phone: +1 608 441-8120
Address: 100 Campus Drive
State: NJ
City / Town: Florham Park
Country: USA
Postal Code: 07932

Issuer Information

Exchange: NSC
CEO: James V. Caruso
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.

Contact Information

Website: www.cellectar.com
Email: epiros@rodmanandrenshaw.com
Main Phone: +1 608 441-8120
Address: 100 Campus Drive
State: NJ
City / Town: Florham Park
Country: USA
Postal Code: 07932

Issuer Information

Exchange: NSC
CEO: James V. Caruso
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.59 $ 0.10 (6.71%)
Last Price 1.59 Change $ 0.10 Change % 6.71 Tick N/A
Bid 1.58 Bid Size 300.00 Ask 1.59 Ask Size 100.00
Open 1.48 High 1.65 Low 1.48 Prev Close 1.49
Last Trade Volume 100,392 52 Wk Hi 3.75 52 Wk Low 1.22
Market Cap 14.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 9,396,036.00 EPS (TTM) -2.81 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 0
Number of Sells 0 3
Net Activity 0 -52214
Last 10 Buys Shares
John P. Neis 1,000
John P. Neis 1,000
Stephen A. Hill 1,000
Paul L. Berns 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
Marxe W Austin 1,000
Last 10 Sell Shares
Jarrod Longcor 1,000
James V. Caruso 1,000
John P. Neis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.1 3.1 3.1 3.1
Low Target Price Estimate 3.1 3.1 3.1 3.1
Mean Target Price Estimate 3.1 3.1 3.1 3.1
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/25/18 05/25/18 04/02/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1